SCHMIDT ERIC THOMAS
Insider CIK 1754403 · RLMD Director · RVMD Director · ALLO Chief Financial Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| RVMD Revolution Medicines, Inc. | A Award deriv | 2023-06-08 | 2023-06-12 | 18,400 | — | $0 | 18,400 | SEC↗ |
| RVMD Revolution Medicines, Inc. | A Award | 2023-06-08 | 2023-06-12 | 5,200 | — | $0 | 21,251 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | A Award deriv | 2023-05-25 | 2023-05-30 | 92,958 | — | $0 | 150,000 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | A Award deriv | 2023-03-22 | 2023-03-24 | 432,738 | — | $0 | 432,738 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | A Award | 2023-03-22 | 2023-03-24 | 558,094 | — | $0 | 862,439 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | F Tax w/h | 2023-03-14 | 2023-03-16 | 35,879 | $5.47 | $196.3K | 304,345 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | A Award deriv | 2022-12-16 | 2022-12-20 | 57,042 | — | $0 | 57,042 | SEC↗ |
| RVMD Revolution Medicines, Inc. | A Award deriv | 2022-06-16 | 2022-06-17 | 18,400 | — | $0 | 18,400 | SEC↗ |
| RVMD Revolution Medicines, Inc. | A Award | 2022-06-16 | 2022-06-17 | 5,200 | — | $0 | 16,051 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | A Award deriv | 2022-05-25 | 2022-05-26 | 91,235 | — | $0 | 150,000 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | A Award deriv | 2022-03-23 | 2022-03-25 | 368,589 | — | $0 | 368,589 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | A Award | 2022-03-23 | 2022-03-25 | 237,358 | — | $0 | 337,904 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | S Sale | 2022-03-15 | 2022-03-17 | 11,469 | $7.63 | $87.5K | 100,546 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | A Award deriv | 2021-12-17 | 2021-12-21 | 58,765 | — | $0 | 58,765 | SEC↗ |
| RVMD Revolution Medicines, Inc. | A Award deriv | 2021-06-22 | 2021-06-24 | 12,659 | — | $0 | 12,659 | SEC↗ |
| RVMD Revolution Medicines, Inc. | A Award | 2021-06-22 | 2021-06-24 | 3,617 | — | $0 | 10,851 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | M Exercise deriv | 2021-05-24 | 2021-05-26 | 14,897 | — | $0 | 94,703 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | M Exercise | 2021-05-24 | 2021-05-26 | 14,897 | $18.22 | $271.4K | 110,994 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | A Award deriv | 2021-03-26 | 2021-03-30 | 92,365 | — | $0 | 92,365 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | A Award | 2021-03-26 | 2021-03-30 | 24,866 | — | $0 | 96,097 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | S Sale | 2021-03-15 | 2021-03-17 | 8,053 | $38.23 | $307.9K | 71,231 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | S Sale | 2021-01-15 | 2021-01-19 | 400 | $33.29 | $13.3K | 1,152,595 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | S Sale | 2021-01-15 | 2021-01-19 | 3,547 | $31.69 | $112.4K | 1,164,048 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | S Sale | 2021-01-15 | 2021-01-19 | 11,053 | $32.40 | $358.1K | 1,152,995 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | S Sale | 2021-01-14 | 2021-01-19 | 9,851 | $30.60 | $301.4K | 1,172,744 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | S Sale | 2021-01-14 | 2021-01-19 | 5,149 | $31.10 | $160.1K | 1,167,595 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | A Award deriv | 2021-01-07 | 2021-01-11 | 100,000 | — | $0 | 100,000 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | S Sale | 2020-11-16 | 2020-11-18 | 10,366 | $33.00 | $342.1K | 1,182,595 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | S Sale | 2020-11-16 | 2020-11-18 | 4,634 | $32.60 | $151.1K | 1,192,961 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | S Sale | 2020-10-15 | 2020-10-16 | 3,479 | $41.33 | $143.8K | 1,199,794 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | S Sale | 2020-10-15 | 2020-10-16 | 4,218 | $40.07 | $169.0K | 1,203,273 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | S Sale | 2020-10-15 | 2020-10-16 | 5,104 | $39.47 | $201.5K | 1,207,491 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | S Sale | 2020-10-15 | 2020-10-16 | 100 | $43.01 | $4.3K | 1,197,595 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | S Sale | 2020-10-15 | 2020-10-16 | 2,099 | $42.32 | $88.8K | 1,197,695 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | S Sale | 2020-09-21 | 2020-09-22 | 1,911 | $37.04 | $70.8K | 1,212,595 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | S Sale | 2020-09-21 | 2020-09-22 | 9,889 | $34.76 | $343.7K | 1,217,706 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | S Sale | 2020-09-21 | 2020-09-22 | 3,200 | $35.96 | $115.1K | 1,214,506 | SEC↗ |
| RVMD Revolution Medicines, Inc. | A Award deriv | 2020-06-17 | 2020-06-19 | 25,318 | — | $0 | 25,318 | SEC↗ |
| RVMD Revolution Medicines, Inc. | A Award | 2020-06-17 | 2020-06-19 | 7,234 | — | $0 | 7,234 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | X Exercise deriv | 2020-04-09 | 2020-04-09 | 32,500 | $6.00 | $195.0K | 0 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | X Exercise deriv | 2020-04-09 | 2020-04-09 | 12,500 | $9.00 | $112.5K | 0 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | X Exercise | 2020-04-09 | 2020-04-09 | 32,500 | $6.00 | $195.0K | 87,500 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | X Exercise | 2020-04-09 | 2020-04-09 | 12,500 | $9.00 | $112.5K | 100,000 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | A Award deriv | 2020-03-18 | 2020-03-20 | 109,600 | — | $0 | 109,600 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | A Award | 2020-03-18 | 2020-03-20 | 30,800 | — | $0 | 78,706 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | S Sale | 2020-03-16 | 2020-03-18 | 300 | $20.25 | $6.1K | 47,906 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | S Sale | 2020-03-16 | 2020-03-18 | 5,150 | $19.70 | $101.5K | 47,257 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | J Other | 2020-02-20 | 2020-02-24 | 237,155 | $25.30 | $6.00M | 1,227,595 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | A Award deriv | 2019-03-13 | 2019-03-15 | 83,500 | — | $0 | 83,500 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | A Award | 2019-03-13 | 2019-03-15 | 49,400 | — | $0 | 49,400 | SEC↗ |